WRN Background Information Werner’s Syndrome (WS), also called adult progeria, is an inherited, autosomal recessive disorder that is most common in families from regions of Japan where consanguineous marriages occur frequently (1-3). WS is characterized by premature aging and the early onset of age-related diseases and commonly results in cancer (4,5). The gene responsible for Werner’s Syndrome, WRN, has been mapped to the short arm of chromosome 8, 8p11.2-p12 and the subsequent cloning of the gene has reveled a predicted protein of 1432 amino acids in length, that bears significant sequence homology with DNA helicases (6,7). Four mutations in WRN have been identified in patients afflicted with WS (7). Two of the mutations involve mRNA splice-junctions. Of these two mutations, one was found in 60 percent of the individuals
examined (7). This mutation is predicted to cause a frameshift which results in a truncated WRN protein (7).
WRN (H-300) Product Citations
See how others have used WRN (H-300): sc-5629 antibody and or WRN (H-300) antibody conjugates.
WRN (H-300): sc-5629. Western blot analysis of WRN expression in K-562 (A) and KNRK (B) nuclear extracts.
WRN siRNA (h): sc-36843. Western blot analysis of WRN expression in non-transfected control (A) and WRN siRNA transfected (B) HeLa cells. Blot probed with WRN (H-300): sc-5629. α-actinin (H-2): sc-17829 used as specificity and loading control.
WRN (H-300): sc-5629. Western blot analysis of WRN expression in KNRK nuclear extract (A) and NAMALWA whole cell lysate (B).